PAR 14.3% 20.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-95

  1. 1,023 Posts.
    lightbulb Created with Sketch. 314
    If I hear the line “having spoken to Simon” one more time I might just have an aneurism.

    Simon has proven his word doesn’t mean a thing. He took 39KP, a substantial holder, for an absolute ride. As he has done many shareholders on HC.

    Sorry Bob. Certainly not just you having chats with him but, I take no confidence from them.

    Ive held for five years and am absolutely certain this company is kaput. Biopharma just don’t want a part of this. Whether that be because of the IP/ secondary party to IPPS nature of the arrangement.

    Equally, PAR has proven themselves worse than inept at a corporate level. Scotty joining signal just how dire things have gotten. He is by no means a reputable BP operator at all. Rather a fund manager whose performance was so so (thanks in part to PAR).
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.025(14.3%)
Mkt cap ! $70.04M
Open High Low Value Volume
17.5¢ 20.0¢ 16.5¢ $581.1K 3.171M

Buyers (Bids)

No. Vol. Price($)
3 19640 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 68051 1
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.